Symlin pramlintide acetate: Post-marketing study data

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN), San Diego, Calif.
Product: Symlin pramlintide acetate
Business: Endocrine
Molecular

Read the full 146 word article

How to gain access

Continue reading with a
two-week free trial.